SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001903
Filing Date
2023-08-14
Accepted
2023-08-14 16:36:02
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20230630x10q.htm   iXBRL 10-Q 1526611
2 EX-10.1 ckpt-20230630xex10d1.htm EX-10.1 64122
3 EX-31.1 ckpt-20230630xex31d1.htm EX-31.1 9957
4 EX-31.2 ckpt-20230630xex31d2.htm EX-31.2 9890
5 EX-32.1 ckpt-20230630xex32d1.htm EX-32.1 6567
6 EX-32.2 ckpt-20230630xex32d2.htm EX-32.2 6488
  Complete submission text file 0001410578-23-001903.txt   6219322

Data Files

Seq Description Document Type Size
7 EX-101.SCH ckpt-20230630.xsd EX-101.SCH 48090
8 EX-101.CAL ckpt-20230630_cal.xml EX-101.CAL 23027
9 EX-101.DEF ckpt-20230630_def.xml EX-101.DEF 230679
10 EX-101.LAB ckpt-20230630_lab.xml EX-101.LAB 388288
11 EX-101.PRE ckpt-20230630_pre.xml EX-101.PRE 317052
50 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20230630x10q_htm.xml XML 894290
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 231171198
SIC: 2834 Pharmaceutical Preparations